-
Published04/02/2025
-
Today19/02/2025
-
Deadline04/03/2025
-
Opening of tenders10/03/2025
Utilities
SUMINISTRO DE MEDICAMENTOS CON PRINCIPIO ACTIVO ECULIZUMAB PARA EL TRATAMIENTO DE LA HEMOGLOBINURIA PAROXÍSTICA NOCTURNA Y SÍNDROME HEMOLÍTICO URÉMICO CON DESTINO A CENTROS SANITARIOS DEPENDIENTES DEL SERVICIO MURCIANO DE SALUD.
SUMINISTRO DE MEDICAMENTOS CON PRINCIPIO ACTIVO ECULIZUMAB PARA EL TRATAMIENTO DE LA HEMOGLOBINURIA PAROXÍSTICA NOCTURNA Y SÍNDROME HEMOLÍTICO URÉMICO CON DESTINO A CENTROS SANITARIOS DEPENDIENTES DEL SERVICIO MURCIANO DE SALUD.
https://sede.carm.es/sms/licitacion
https://sede.carm.es/sms/licitacion
Type: price
Description: PRECIO
Weight (percentage, exact): 100
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.